Med God Grund A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.1% 1.1%  
Bankruptcy risk  0.0% 0.0% 15.4% 18.1% 15.3%  
Credit score (0-100)  0 0 12 7 12  
Credit rating  N/A N/A BB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 818 635 744  
EBITDA  0.0 0.0 283 95.7 220  
EBIT  0.0 0.0 283 95.7 220  
Pre-tax profit (PTP)  0.0 0.0 -636.0 -2,324.4 -1,108.2  
Net earnings  0.0 0.0 -636.0 -2,324.4 -1,108.2  
Pre-tax profit without non-rec. items  0.0 0.0 -636 -2,324 -1,108  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 -236 -2,560 -3,669  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 0.0 865 276 453  

Net Debt  0.0 0.0 -391 -255 -448  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 818 635 744  
Gross profit growth  0.0% 0.0% 0.0% -22.4% 17.3%  
Employees  0 0 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 865 276 453  
Balance sheet change%  0.0% 0.0% 0.0% -68.0% 63.9%  
Added value  0.0 0.0 283.3 95.7 219.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 2.0 3.0  

Profitability 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 34.7% 15.1% 29.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -54.2% -116.2% -30.6%  
ROI %  0.0% 0.0% 0.0% -374.7% -57.8%  
ROE %  0.0% 0.0% -73.5% -407.3% -303.8%  

Solidity 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 0.0% -21.4% -90.3% -89.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -137.9% -266.1% -203.9%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.0 12.2 1.8 3.0  
Current Ratio  0.0 0.0 12.2 1.8 3.0  
Cash and cash equivalent  0.0 0.0 390.7 254.7 447.9  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 794.0 125.8 301.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 283 96 220  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 283 96 220  
EBIT / employee  0 0 283 96 220  
Net earnings / employee  0 0 -636 -2,324 -1,108